Is F-FDG Metabolic Tumor Volume in Lymphoma Really Happening?
作者信息
Barrington Sally F, Cottereau Anne-Ségolène, Zijlstra Josée M
机构信息
King's College London and Guy's and St. Thomas' PET Centre, School of Biomedical Engineering and Imaging Sciences, King's College London, United Kingdom;
Department of Nuclear Medicine, Cochin Hospital, APHP, Paris Cité University, Paris, France; and.
出版信息
J Nucl Med. 2024 Feb 22;65(4):510-1. doi: 10.2967/jnumed.123.267022.
Abstract
摘要
相似文献
1
Is F-FDG Metabolic Tumor Volume in Lymphoma Really Happening?
J Nucl Med. 2024 Feb 22;65(4):510-1. doi: 10.2967/jnumed.123.267022.
2
Can metabolic tumor parameters on primary staging F-FDG PET/CT aid in risk stratification of primary central nervous system lymphomas for patient management as a prognostic model?
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2018 Jan-Feb;37(1):9-14. doi: 10.1016/j.remn.2017.06.003. Epub 2017 Jul 18.
3
Predictive value of Dmax and %ΔSUVmax of F-FDG PET/CT for the prognosis of patients with diffuse large B-cell lymphoma.
BMC Med Imaging. 2023 Oct 31;23(1):173. doi: 10.1186/s12880-023-01138-8.
4
Prognostic role of baseline F-FDG PET/CT parameters in MALT lymphoma.
Hematol Oncol. 2019 Feb;37(1):39-46. doi: 10.1002/hon.2563. Epub 2018 Nov 8.
5
Multiple metabolic parameters and visual assessment of F-FDG uptake heterogeneity of PET/CT in advanced gastric cancer and primary gastric lymphoma.
Abdom Radiol (NY). 2020 Nov;45(11):3569-3580. doi: 10.1007/s00261-020-02503-9.
6
Correlation between F-FDG PET/CT semiquantitative parameters and Ki-67 expression in pulmonary mucosa-associated lymphoid tissue lymphoma.
J Med Imaging Radiat Oncol. 2021 Apr;65(2):188-194. doi: 10.1111/1754-9485.13146. Epub 2021 Feb 3.
7
The value of FDG PET/CT imaging in outcome prediction and response assessment of lymphoma patients treated with immunotherapy: a meta-analysis and systematic review.
Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4661-4676. doi: 10.1007/s00259-022-05918-2. Epub 2022 Aug 6.
8
[F]Fludarabine-PET as a promising tool for differentiating CNS lymphoma and glioblastoma: Comparative analysis with [F]FDG in human xenograft models.
Theranostics. 2018 Aug 10;8(16):4563-4573. doi: 10.7150/thno.26754. eCollection 2018.
9
Basal (18)F-FDG PET/CT in follicular lymphoma: A comparison of metabolic and clinical variables in the prognostic assessment.
Rev Esp Med Nucl Imagen Mol. 2016 Sep-Oct;35(5):298-305. doi: 10.1016/j.remn.2016.04.003. Epub 2016 Jun 14.
10
Semi-automated F-FDG PET segmentation methods for tumor volume determination in Non-Hodgkin lymphoma patients: a literature review, implementation and multi-threshold evaluation.
Comput Struct Biotechnol J. 2023 Jan 20;21:1102-1114. doi: 10.1016/j.csbj.2023.01.023. eCollection 2023.
引用本文的文献
1
Current Status of Revisions to the Lugano Classification in Lymphoma.
Hematol Oncol. 2025 Jul;43(4):e70103. doi: 10.1002/hon.70103.
2
Prognostic impact of metabolic tumor volume using the SUV4.0 segmentation threshold in 1,960 lymphoma patients from prospective LYSA trials.
Eur J Nucl Med Mol Imaging. 2025 Mar 20. doi: 10.1007/s00259-025-07176-4.
3
Maximum tumor diameter is associated with relapse risk in limited-stage Hodgkin lymphoma: an international study.
Blood Adv. 2025 May 13;9(9):2266-2274. doi: 10.1182/bloodadvances.2024015140.
4
Is Automatic Tumor Segmentation on Whole-Body F-FDG PET Images a Clinical Reality?
J Nucl Med. 2024 Jul 1;65(7):995-997. doi: 10.2967/jnumed.123.267183.
本文引用的文献
1
International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation.
J Nucl Med. 2024 Sep 3;65(9):1343-1348. doi: 10.2967/jnumed.124.267789.
2
Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma.
Blood. 2023 Jun 22;141(25):3055-3064. doi: 10.1182/blood.2022018558.
3
A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphoma.
Blood Adv. 2022 Dec 13;6(23):5995-6004. doi: 10.1182/bloodadvances.2021006923.
4
Combatting the effect of image reconstruction settings on lymphoma [F]FDG PET metabolic tumor volume assessment using various segmentation methods.
EJNMMI Res. 2022 Jul 29;12(1):44. doi: 10.1186/s13550-022-00916-9.
5
Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine-treated, interimPET-negative classical Hodgkin Lymphoma patients: A radio-genomic study.
Hematol Oncol. 2022 Oct;40(4):645-657. doi: 10.1002/hon.3025. Epub 2022 May 30.
6
Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index.
J Clin Oncol. 2022 Jul 20;40(21):2352-2360. doi: 10.1200/JCO.21.02063. Epub 2022 Mar 31.
7
Pre-treatment total metabolic tumour volumes in lymphoma: Does quantity matter?
Br J Haematol. 2022 Apr;197(2):139-155. doi: 10.1111/bjh.18016. Epub 2022 Jan 17.
8
The Impact of Semiautomatic Segmentation Methods on Metabolic Tumor Volume, Intensity, and Dissemination Radiomics in F-FDG PET Scans of Patients with Classical Hodgkin Lymphoma.
J Nucl Med. 2022 Sep;63(9):1424-1430. doi: 10.2967/jnumed.121.263067. Epub 2022 Jan 6.
9
A Guide to ComBat Harmonization of Imaging Biomarkers in Multicenter Studies.
J Nucl Med. 2022 Feb;63(2):172-179. doi: 10.2967/jnumed.121.262464. Epub 2021 Sep 16.
10
Interobserver Agreement on Automated Metabolic Tumor Volume Measurements of Deauville Score 4 and 5 Lesions at Interim F-FDG PET in Diffuse Large B-Cell Lymphoma.
J Nucl Med. 2021 Nov;62(11):1531-1536. doi: 10.2967/jnumed.120.258673. Epub 2021 Mar 5.
Zotero 插件